logo
The Pandemic Literally Aged Our Brains

The Pandemic Literally Aged Our Brains

Medscape22-07-2025
This transcript has been edited for clarity.
Welcome to Impact Factor , your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson from the Yale School of Medicine.
Living through the COVID pandemic aged your brain by about five and a half extra months. This, according to new research. It's a pretty scary headline, but what does 'brain age' even mean, how do you measure it, and what risks does a five-and-a-half month older brain have to face?
We're going to use what's left of our brains to dig through the data this week. Stay tuned.
The study generating those scary headlines is 'Accelerated Brain Ageing During the COVID-19 Pandemic', from Ali-Reza Mohammadi-Nejad and colleagues, appearing in Nature Communications .
But before we get into it, a reminder that SARS-CoV-2, the virus that caused the COVID-19 pandemic, is a weird one, especially when it comes to the brain. It was pretty early in the pandemic when we realized that one of the rather unique symptoms that came with COVID infection, differentiating it from the common cold and flu infections and the like, was anosmia — the loss of smell. It turned out this was due to infection of some epithelial cells in the nose, with inflammation impacting the olfactory bulb of the brain.
To be clear, evidence of direct brain infection by SARS-CoV-2 is fairly weak. Neurons don't express high levels of the ACE2 receptor — the viruses' point of entry to other cells. And while some autopsy studies have found viral genetic material in the brain, it has been quite difficult to find live virus in brain cells.
But secondary effects of the virus — inflammation and microclotting— do affect the brain. And multiplestudies have suggested that infection can worsen certain cognitive outcomes.
There was more to the pandemic than just the virus, though. There was social isolation, higher levels of stress, and loss of work and other cognitively stimulating activities. In other words, there were lots of reasons for people's brains to get a little worse during those few years.
That's really what the Nature Communications study is looking at. It's an overall sense of how our brains are doing, and 'brain age' is a useful proxy for that concept.
So, what is brain age? It's pretty straightforward. Imagine a carnival barker doing the 'guess your age' thing. You come up, they take a look at you, squint, and call out a number, usually with startling accuracy. The carnival barker is using various clues — features on your face, wrinkles, hairstyle, and so on — to make a guess.
We can do the same thing with an MRI machine. We just have to teach a computer what the brains of different ages look like.
That's what researchers did here. Using the huge UK biobank cohort, they took brain scans of more than 15,000 healthy people of various ages and trained a machine-learning model to predict age based just on the images.
It got pretty accurate, as you can see here.
Of course, it's not perfect. Nor would we expect it to be. Some people's brains look younger than their stated age. Call it the Paul Rudd effect. And, of course, some brains look older than they should.
The distance between your calendar age and your brain age is the 'brain age gap' (BAG), with higher numbers implying that your brain is older than it should be. This gap seems to stay pretty consistent over time. If your BAG is 5 years right now, it tends to stay around 5 years even a few years later, provided nothing intervenes to more rapidly age your brain.
If anyone ever accuses you of having an excessive BAG, you can say 'that's not my bag, baby.' (And that ends the '90s references for this week.)
It's the repeated brain scans that make this study interesting. The researchers identified about 1000 participants who had multiple brain scans, on average about 2 years apart. For 432 of those folks, the pandemic happened between the two scans. So, we can look at how much their brains aged in that timeframe and compare that aging to a group who was not exposed to the pandemic. This is the meat of the study.
Here are the primary results. Remember, BAG is supposed to stay pretty stable if nothing else has changed. And that's what we see in the control group. Between the two scans, there was, on average, no change in BAG — though the distribution here encompasses changes in both directions.
Now we add the pandemic group. What you see is that the distribution has shifted, on average by 5.5 months. That's where we get that headline that started this whole thing. But of course, 5.5 is just the average change in BAG. Different people's brains aged at different speeds. Still, overall, this is a statistically significant difference.
You're probably wondering why some brains aged more than others. The 5.5 month result is the effect of the pandemic – not necessarily infection. Out of the 432 individuals with a postpandemic scan, 134 actually had documented COVID-19 before that second scan. Interestingly, the increase in brain age was similar among those infected and those not infected.
To be fair, only five of those infected were sick enough to be hospitalized, but it still seems that the bulk of the aging effect of the pandemic may have been due to factors independent of the virus itself; factors that made the pandemic effect worse. The brains of older people and men seemed to age more during the pandemic than those of younger people and women. Poor socioeconomic status and lower education also led to more pandemic brain aging.
Still, it's not how you look; it's how you feel. Do older-looking brains on brain scans function worse? The study doesn't offer much support for this. Cognitive testing found no compelling relationship between changes in brain age and changes in various tests of cognitive ability across the entire cohort. There did seem to be some relationship among those infected with COVID-19: They did worse on cognitive tests if their brains had aged more than expected. But I'm often wary of signals like this that appear in a very particular subgroup.
Leaving the realm of data and stepping squarely into the land of speculation, I think what we are likely seeing here is that the pandemic was a population-wide neurologic stressor. The isolation, the anxiety, and the lack of cognitive stimulation led our brains to atrophy a bit. It does not seem that this is a direct result of viral infection, though again, we don't have data on people with more severe COVID-19.
The big question is, what happens next? Now that we are reintegrated with society, back at work, and using our brains a bit more, will they grow younger again? It remains to be seen. But if the pandemic-induced gray in my hair is any indicator, there may be no going back.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Palvella Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
Palvella Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference

Yahoo

time23 minutes ago

  • Yahoo

Palvella Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference

WAYNE, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no Food and Drug Administration (FDA)-approved therapies, today announced that Wes Kaupinen, Founder and Chief Executive Officer of Palvella, will participate in a fireside chat at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, at 1:00 p.m. ET. A live webcast of the fireside chat will be available on the Events and Presentations section of Palvella's website at An archived replay of the webcast will be available for approximately 90 days following the presentation. About Palvella TherapeuticsFounded and led by rare disease drug development veterans, Palvella Therapeutics, Inc. (Nasdaq: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. Palvella is developing a broad pipeline of product candidates based on its patented QTORIN™ platform, with an initial focus on serious, rare genetic skin diseases, many of which are lifelong in nature. Palvella's lead product candidate, QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin), is currently being evaluated in the Phase 3 SELVA clinical trial in microcystic lymphatic malformations and the Phase 2 TOIVA clinical trial in cutaneous venous malformations. For more information, please visit or follow Palvella on LinkedIn or X (formerly known as Twitter). QTORIN™ rapamycin is for investigational use only and has not been approved or cleared by the FDA or by any other regulatory agency for any Information InvestorsWesley H. KaupinenFounder and CEO, Palvella MediaMarcy NanusManaging Partner, Trilon Advisors, LLCmnanus@

Altimmune to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025
Altimmune to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025

Yahoo

time23 minutes ago

  • Yahoo

Altimmune to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025

GAITHERSBURG, Md., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will report its second quarter 2025 financial results on Tuesday, August 12, 2025. Altimmune management will host a conference call at 8:30 am E.T. on August 12 to discuss financial results and provide a business update. The conference call will be webcast live on Altimmune's Investor Relations website at Participants who would like to join the call may register here to receive the dial-in numbers and unique PIN to access the call. Shortly after the call, a replay will be available on the Investor Relations website for up to three months. About Altimmune Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases. The Company's lead program is pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Alcohol Use Disorder (AUD), Alcohol-Associated Liver Disease (ALD) and obesity. For more information, please visit Follow @Altimmune, Inc. on LinkedInFollow @AltimmuneInc on X Company Contact:Greg WeaverChief Financial OfficerPhone: 240-654-1450ir@ Investor Contact:Lee RothBurns McClellanPhone: 646-382-3403lroth@ Media Contact:Jake RobisonInizio Evoke, BiotechPhone: This press release was published by a CLEAR® Verified in to access your portfolio

'Flesh-eating' bacteria cases are popping up along the Gulf Coast. What you need to know.
'Flesh-eating' bacteria cases are popping up along the Gulf Coast. What you need to know.

Yahoo

time23 minutes ago

  • Yahoo

'Flesh-eating' bacteria cases are popping up along the Gulf Coast. What you need to know.

As temperatures continue to swelter and people flock to the Gulf Coast to enjoy its warm, salty waters, health officials are warning swimmers about a "flesh-eating" bacteria that has killed at least eight people this summer. The bacterium, Vibrio vulnificus, is commonly associated with the "flesh-eating" moniker thanks to its ability to cause infections that damage or "eat away" at skin and tissue. This year, Louisiana is reporting an abnormally high rate of infection. "Amid increasing water temperatures and extreme weather events (e.g., heat waves, flooding, and severe storms), people who are at increased risk for V. vulnificus infection (those with weakened immune systems and conditions like liver disease, diabetes and kidney failure) ... should exercise caution when engaging in coastal water activities," said a Louisiana Department of Health warning issued July 30. Despite a recent uptick in cases, Vibrio vulnificus infections are still rare. Even so, experts have advised that people in coastal areas exercise extra caution while enjoying the waning days of summer. Here's what to know. Dangerous waters: What to know about the flesh-eating bacteria and brain-eating amoebas Where are flesh-eating bacteria cases in the US? How common is it? Louisiana has reported the highest number of Vibrio vulnificus infections in a decade, with 17 reported cases and hospitalizations, including four deaths, as of July 30. This is compared to the 10 years prior, which saw an average of only seven cases and one death during the same time period. Florida has likewise reported four deaths caused by Vibrio vulnificus infections as of July 24. The state has counted 13 total cases so far, a rate that isn't necessarily abnormal at this point in the year, according to Florida health data. An average of 150 to 200 cases are reported each year, with most of them in Gulf Coast states, according to CDC data. USA TODAY has reached out to health departments in other coastal states regarding possible cases. What is Vibrio vulnificus? Vibrio vulnificus is a bacterium that causes a serious infection called vibriosis. Different types of Vibrio bacteria cause different infections, with Vibrio vulnificus causing the "most serious forms of vibriosis," according to the Cleveland Clinic. The potentially fatal infection can quickly result in tissue damage and spreading blisters, low blood pressure, fever, organ damage, sepsis and death. Vibrio vulnificus is often referred to as "flesh-eating" because it can also cause necrotizing fasciitis, a bacterial infection that destroys muscle and skin tissue, causing flesh around wounds to die, according to the CDC. While it is possible, Vibrio vulnificus is not considered to be the most common cause of necrotizing fasciitis in the U.S. The bacteria and resulting infections are rare but can be life-threatening. Without treatment, death can occur in just a few days. How does 'flesh-eating' bacteria enter the body? Vibrio vulnificus requires salt water for survival and thrives in warm, brackish water where a stream or river meets seawater, according to the CDC. Most infections occur when contaminated water is swallowed or gets into an open wound, such as a cut or scrape. It can enter through broken skin but cannot penetrate unharmed skin. Vibrio vulnificus can also enter your body when you eat uncooked or undercooked shellfish, especially oysters. In fact, raw oysters and other seafood, along with seawater exposure, are the most common sources of Vibrio outbreaks tracked by the CDC. Once inside the body, it can spread quickly to the blood and organs, usually within a matter of hours. Symptoms of Vibrio vulnificus infection Symptoms of a Vibrio vulnificus infection begin suddenly and quickly, usually less than 24 hours after exposure, according to the CDC and Cleveland Clinic. Common symptoms include: Fever and chills A red, warm or swollen patch of skin or rash that spreads quickly and causes pain Fluid-filled blisters and skin discoloration Nausea, vomiting and diarrhea Low blood pressure (often indicated by weakness, dizziness, fatigue and fainting) Confusion or altered mental state Rapid heartbeat How to protect yourself against Vibrio vulnificus When consuming seafood, advises the CDC, you should: Cook seafood, including oysters, before consuming. Thoroughly clean surfaces that may have come in contact with raw seafood and its drippings. Thoroughly wash your hands after handling raw seafood. If you are at high risk, wear gloves. When swimming, you should: Avoid entering saltwater or brackish water if you have any open wounds. This includes recent surgical sites, fresh tattoos and piercings and even minor cuts or scrapes. Cover any open wounds if you may come into contact with coastal waters or raw seafood, even if you don't plan to be directly exposed to either. Exposure can also happen during flooding caused by storms. Immediately wash any area of open skin with soap and running water after contact with coastal water or raw seafood. If you are at increased risk (people with weakened immune systems and conditions like liver disease, diabetes and kidney failure), wear protective shoes and clothes when in or near coastal waters. Contributing: Janet Loehrke, USA TODAY This article originally appeared on USA TODAY: 'Flesh-eating' bacteria cases are on the rise in US. What to know. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store